Announced Mon, 29 Jun · 15:44 IST
Trading window closed from July 1 for Q1 FY27 results
Compliance View source PDF
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.0%1-day move
₹531.00
prior close
₹538.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.7-0.8+0.8-2.0-1.0-5.1-7.7-4.5-0.8-11.9———
Up moveDown movePending
AI summary
Bliss GVS Pharma has closed its trading window from July 1, 2026, until 48 hours after the announcement of unaudited financial results for Q1 FY27 (quarter ended June 30, 2026). Insiders, designated persons, and their immediate relatives cannot trade in company shares during this period. This is a routine SEBI compliance filing under Insider Trading Regulations. Board meeting date for Q1 results will be announced later.
Likely market impact
Routine compliance filing. No insider trading allowed until Q1 results are out. Watch for upcoming results announcement date.